A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis

NCT03496571 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Eosinophilic Gastritis
Eosinophilic Gastroenteritis

Interventions

DRUG: AK002
OTHER: Placebo

Sponsor

Allakos Inc.